Latest News

SK hynix to establish U.S. arm specialized in AI solutions

-  'AI Company,' aims to become a key partner in the AI data center ecosystem -  As the hub for SK Group's AI strategies, AI Co. will help accelerate AI advancement in global markets, including US and S. Korea. -  "SK hynix will proactively seize opportunities in the upcoming AI era and deliver ex...

2026-01-28 17:18 10301

SK hynix Announces FY25 Financial Results… Posts Record-High Results and Delivers Highest Shareholder Returns

* Achieves all-time high annual and quarterly results, driven by AI memory competitiveness and high value-added products including HBM * Reports FY2025 revenue of 97.1467 trillion won, operating profit of 47.2063 trillion won, net profit of 42.9479 trillion won * Reports 4Q25 revenue of 32.8...

2026-01-28 16:42 20871

Youdao to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11

HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- Youdao, Inc. ("Youdao" or the "Company") (NYSE:DAO), an AI-powered solutions provider specializing in artificial intelligence applications for the learning and advertising verticals, today announced that it will report its fourth quarter and fiscal ...

2026-01-28 16:30 5794

NetEase to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 11

HANGZHOU, China, Jan. 28, 2026 /PRNewswire/ -- NetEase, Inc. (NASDAQ: NTES and HKEX: 9999, "NetEase" or the "Company"), a leading internet and game services provider, today announced that it will report financial results for the fourth quarter and fiscal year 2025 onWednesday, February 11, 2026, ...

2026-01-28 16:30 6948

Mobile Legends: Bang Bang charts global ambitions with five-region esports overhaul, M8 World Championship breaks ground in Türkiye and Thailand

* MLBB is the first confirmed title for the inaugural Esports Nation Cup (ENC) 2026 and will debut as a medalled event at the 20th Asian Games Aichi-Nagoya 2026. * MLBB Esports unveiled a new intercontinental tournament piloting across AMER, EA, and SEA—the Championship Tour—to elevate region...

2026-01-28 14:02 10755

Hanmi Secures Export Deal with Mexican Partner Sanfer for GLP-1 Obesity Drug and More

Hanmi Signs Exclusive Partnership with New Mexican Partner Laboratorios Sanfer, Covering Efpeglenatide and Diabetes Treatments  SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- Hanmi is accelerating its global market entry with efpeglenatide, Korea's first domestically developed GLP-1 class obes...

2026-01-28 12:08 6758

Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology

* The Institute has placed #1 in ophthalmology among all non-academic institutes, and #2 in the same field among all institutes, globally. SINGAPORE, Jan. 27, 2026 /PRNewswire/ -- The Singapore Eye Research Institute (SERI) has achieved a landmark milestone inDecember 2025 by securing first pla...

2026-01-28 10:00 4112

MegazoneCloud and Hana Bank Partner to Develop Innovative Digital Financial Services

* Co-development of innovative financial services powered by advanced digital technologies such as AI, cloud, and data science * Strategic cooperation on trade finance for large-scale GPU and NPU server imports aligned with the government's Global Top 3 AI initiative SEOUL, South Korea, Jan. ...

2026-01-28 09:51 7878

Enhancing Workflow Efficiency with Monport's Fiber Laser and CO2 Laser Systems This Winter

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As manufacturers and creative professionals seek ways to maximize productivity, advanced laser systems have become a critical tool for precision, speed, and versatility.Fiber laser engravers for metal

2026-01-28 07:08 6560

Dreame Unveils "Beyond Smart" Home Ecosystem in Silicon Valley, Showcasing a Future of Robotic Autonomy and AI-Powered Living

SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- Dreame Technology,   a global leader in high-end consumer electronics and intelligent manufacturing, today launched its visionary 2026 home appliance lineu...

2026-01-28 06:00 9206

Finding each other through the algorithm: one year as a 'local' on China's social media: Global Times

BEIJING, Jan. 27, 2026 /PRNewswire/ -- Many American users who initially joined Xiaohongshu, a Chinese app for sharing daily life, a year ago following a looming TikTok ban - often referred to as "TikTok refugees" - have become what they now call "Xiaohongshu locals." Netizens fromChina and the U...

2026-01-27 23:41 8798

Official Launch: The World's First AI Platform Built Specifically for Family Life

Introducing Nori, a system-level AI designed for shared coordination across modern families SAN FRANCISCO, Jan. 27, 2026 /PRNewswire/ -- Domus Next Inc. today announced the launch of Nori, the world's first AI built specifically for family life. Designed from inception as a shared system rather ...

2026-01-27 23:39 8221

AllsWell Marks Consecutive Appearances at CES: From Managed Brand PR to GEO, Advancing Brand Growth in the Generative Search Era

At CES 2026, AllsWell Announces Strategic Partnership with LEAP GEO to Help Brands Move from Exposure to AI Citations and Recommendations LAS VEGAS, Jan. 27, 2026 /PRNewswire/ -- Global brand communications and public relations consultancyAllsWell announced at the 2026 Consumer Electronics Show ...

2026-01-27 23:15 6848

FutureMain Bolsters Global Industrial AI Competitiveness with NPU-Based Time-Series AI Project

SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- FutureMain Co., Ltd. , a specialized industrial AI company focused on equipment diagnostics and predictive maintenance, announced that it is playing a pivotal role in a next-generation intelligent semiconductor R&D proj...

2026-01-27 22:00 4780

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies

CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center...

2026-01-27 22:00 9743

Asthma and Allergy Drug Development Is Failing Too Often--A Translational Reset Is Needed: HKEY-AIRx™1.0

BOSTON and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ -- HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy,HKEY-AIRxTM1.0  designed to address one of the most persistent problems facing biotech leadership: w...

2026-01-27 22:00 7591

Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos

International trade shows highlight Eworld's energy-efficient glass processing technologies for architectural and industrial applications JINAN, China, Jan. 27, 2026 /PRNewswire/ -- High energy costs and tightening environmental regulations are no longer just future concerns; they are the immedi...

2026-01-27 21:47 8102

Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio

SEATTLE, Jan. 27, 2026 /PRNewswire/ -- As modern homes continue to evolve, consumers are increasingly seeking appliances that combine performance, thoughtful design, and long-term value.Tineco , a leader in intelligent floor care solutions, brings this philosophy to life ...

2026-01-27 21:46 7798

Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment

Top ranked women's basketball recruit Jerzy Robinson marks a defining life chapter through self-expression with Beetles Gel Polish. NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As young athletes navigate high-pressure moments both on and off the court, Beetles Gel Polish reinforces its long-standing ...

2026-01-27 21:32 8654

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....

2026-01-27 21:00 10527